PanGen Biotech Inc. (KOSDAQ:222110)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,300.00
0.00 (0.00%)
At close: Feb 19, 2026
Market Cap70.17B +6.9%
Revenue (ttm)15.27B +11.3%
Net Income1.64B
EPS126.75
Shares Out13.49M
PE Ratio41.03
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,534
Average Volume18,789
Open5,290.00
Previous Closen/a
Day's Range5,250.00 - 5,340.00
52-Week Range4,305.00 - 7,400.00
Beta-0.16
RSI44.23
Earnings Daten/a

About PanGen Biotech

PanGen Biotech Inc. operates as a biologics company in South Korea. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production. In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service. PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 222110
Full Company Profile

Financial Performance

Financial Statements